CHC
VRTX icon

City Holding Co’s Vertex Pharmaceuticals VRTX Stock Holding History

City Holding Co’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.3K Buy
73
+41
+128% +$18.2K ﹤0.01% 384
2026
Q1 		$14.3K Hold
32
– – ﹤0.01% 440
2025
Q4 		$14.5K Hold
32
– – ﹤0.01% 443
2025
Q3 		$12.5K Buy
+32
New +$13.4K ﹤0.01% 471

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

City Holding Co's VRTX Position: Q2 2026 in Review

City Holding Co increased its Vertex Pharmaceuticals (VRTX) stake by 128% in Q2 2026, buying an estimated $18.2K and bringing the position to 73 shares worth $36.3K. The position accounts for ﹤0.01% of the portfolio, ranked #384.

City Holding Co first reported a position in VRTX in Q3 2025 and has held it in 4 quarters since. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • City Holding Co held 73 shares of Vertex Pharmaceuticals worth $36.3K as of Q2 2026.
  • City Holding Co bought 41 Vertex Pharmaceuticals shares in Q2 2026, an estimated $18.2K.
  • Vertex Pharmaceuticals made up ﹤0.01% of City Holding Co's portfolio in Q2 2026, its #384 holding.
  • City Holding Co first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on City Holding Co's 13F filing for Q2 2026, filed 10 Jul 2026.